Caricamento...
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors immediately reduce the glomerular filtration rate (GFR) in patients with type 2 diabetes mellitus. When given chronically, they confer benefit by markedly slowing the rate at which chronic kidney disease progresses and are the first agents to do so...
Salvato in:
| Pubblicato in: | Am J Cardiol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7258222/ https://ncbi.nlm.nih.gov/pubmed/31741437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.10.027 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|